Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06138613 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

StatusActive, Not Recruiting
PhasePhase 3
Started2023-02-27
View on ClinicalTrials.gov ↗

Amendment history

2026-04-15
Study Status v4
Primary completion date2026-05-30→2027-09-30
Completion date2026-06-30→2027-12-30
2025-11-17
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v3
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2025-04-30→2026-05-30
Completion date2025-04-30→2026-06-30
Enrollment targetestimated 500→confirmed 705
Study sitesdetails revised at 1 of 1 site
2024-03-20
Study Status v2
Primary completion date2024-07-30→2025-04-30
Completion date2024-07-30→2025-04-30
2024-03-12
Study Status, Study Design v1
Enrollment target300→500
2023-11-13
Original filing
An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel
Trial Details
NCT Number NCT06138613
Lead Sponsor Vanda Pharmaceuticals
Conditions Motion Sickness
Enrollment 705 participants
Start Date 2023-02-27
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-16